Literature DB >> 29259344

Targeted therapies: Strategies for mature T cell cancers.

Megan Cully1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29259344     DOI： 10.1038/nrc.2017.124

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2 in total

1.  Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies.

Authors:  Paul M Maciocia; Patrycja A Wawrzyniecka; Brian Philip; Ida Ricciardelli; Ayse U Akarca; Shimobi C Onuoha; Mateusz Legut; David K Cole; Andrew K Sewell; Giuseppe Gritti; Joan Somja; Miguel A Piris; Karl S Peggs; David C Linch; Teresa Marafioti; Martin A Pule
Journal:  Nat Med       Date:  2017-11-13       Impact factor: 53.440

2.  PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.

Authors:  Tim Wartewig; Zsuzsanna Kurgyis; Selina Keppler; Konstanze Pechloff; Erik Hameister; Rupert Öllinger; Roman Maresch; Thorsten Buch; Katja Steiger; Christof Winter; Roland Rad; Jürgen Ruland
Journal:  Nature       Date:  2017-11-15       Impact factor: 49.962
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.